Etoposide, Topoisomerase II and Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 4, 2005-01 ,pp. : 363-372

Bentham Science Publishers

Access to resources Recommend Favorite

Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC

By                  

International Journal of Oncology, Vol. 41, Iss. 6, 2012-01 ,pp. : 1943-1949

Spandidos Publications

Access to resources Recommend Favorite

Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity

By Uesaka Toshio   Shono Tadahisa   Kuga Daisuke   Suzuki Satoshi   Niiro Hiroaki   Miyamoto Kyoko   Matsumoto Kenichi   Mizoguchi Masahiro   Ohta Masaru   Iwaki Toru   Sasaki Tomio  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 119-129

Springer Publishing Company

Access to resources Recommend Favorite

Adenovirus-mediated human topoisomerase II gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells

By Asano Takeshi   Kleinerman Eugenie   Zwelling Leonard   Zhou Zhichao   Fukunaga Yoshitaka  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 240-247

Informa Healthcare

Access to resources Recommend Favorite

Etoposide Sensitivity and Topoisomerase II Activity in Chinese Hamster V79 Monolayers and Small Spheroids

By Olive P.L.   Durand R.E.   Banáth J.P.   Evans H.H.  

International Journal of Radiation Biology, Vol. 60, Iss. 3, 1991-09 ,pp. : 453-466

Informa Healthcare

Access to resources Recommend Favorite